Subscribe
Subscribe to IHE
Institute of Health Economics logo
My IHE Login
  • About IHE
    • About
    • History
    • Board of Directors
    • Partnerships & Affiliations
    • Lay Advisory Committee
    • Staff Directory
    • Careers and Awards
  • Research & Programs
    • Guideline Adaptation and Development
    • Health Economics
    • Health Technology Assessment, Evidence Reviews, and Evaluation
    • Industry Partnerships
    • Knowledge Transfer
    • Research Methodology Development
  • Publications
  • Events
    • Upcoming Events
    • Past Events
  • News
    • News
  • Contract Our Services
  • IHE In Your Pocket Series
    • MHIYP 2019
Home / Advanced Search

Advanced Search

Result Type

  • Publications
    • All Publications
    • Books
    • Consensus Statements
    • Economic Reports
    • Health Technology Assessments /
      Systematic Reviews
    • Health Topic Overviews / Scoping Reviews
    • Journal Articles
    • Methodology Papers
    • Overview of Systematic Reviews
    • Rapid Reviews
    • Statistics Handbooks
    • Summary Reports
  • Other Resources
    • All Resources
    • Backgrounders
    • Clinical Practice Guidelines
    • Clinical Tools
    • Event Proceedings
    • Patient Resources
    • Presentations
    • Programs
  • News/Events
  • General Content

Years

  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 1996-2010
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000
    • 1999
    • 1998
    • 1997
    • 1996

Topics

  • Cancer
  • Chronic Diseases / Disorders
  • Diabetes
  • Diagnosis
  • Fetal Alcohol Spectrum Disorder (FASD)
  • Health Economics / Healthcare Costs
  • Health Measurement Tools
  • Health Policy
  • Healthcare Services
  • Infectious Diseases
  • Maternal and Child Health
  • Mental Health
  • Other
  • Pharmaceuticals
  • Prevention
  • Quality of Life
  • Screening
  • Surveillance
  • Telehealth
  • Therapy

Authors

  • Armijo-Olivo, Susan
  • Brown, Jasmine
  • Chojecki, Dagmara
  • Corabian, Paula
  • Escober-Doran, Carissa
  • Guo, Bing
  • Husereau, Don
  • Institute of Health Economics, IHE
  • Jacobs, Philip
  • Moga, Carmen
  • Nguyen, Thanh
  • Ohinmaa, Arto
  • Scott, Ann
  • Sproule, John
  • Thompson, Angus
  • Tjosvold, Lisa
  • Yan, Charles

The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.

If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!

Refine your search by clicking filters to the left.

Results for: IHE Institute of Health Economics

Endovascular therapy for acute ischemic stroke

August 24, 2017

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This STE report examines the social and system demographics, technological safety and therapeutic efficacy/effectiveness, cost-effectiveness, and budget impact of endovascular therapy for acute ischemic stroke, contextualized to the Alberta setting. Section Authors: Section…

Real-world evidence: What role can it play in real-world decision making? Summary Report

June 09, 2017

| IHE Institute of Health Economics

This report provides a summary of the IHE Real-World Evidence Roundtable, which took place on December 12, 2016. The intent of the roundtable was to capture initial thinking regarding preferences and perceptions of the use of real-world evidence for pricing and reimbursement of new medicines in Canada and what more may be needed.

Towards a framework for biosimilar evidence and knowledge exchange: Summary report of the IHE Biosimilars Forum

June 06, 2017

| IHE Institute of Health Economics

This report provides a summary of the IHE Biosimilars Forum engagement exercise that took place on April 23, 2017 in Ottawa, Ontario. The intent of the forum was to identify: options to categorize and consider biosimilars; a process to engage stakeholders to identify place in therapy and further evidence development that may be required; and an approach to knowledge exchange that…

Towards an Alberta approach for biosimilar reimbursement

November 22, 2016

| IHE Institute of Health Economics

This report provides a summary of the IHE Biosimilars Forum engagement exercise that took place on October 6, 2016 in Edmonton. The intent of the forum was to inform Alberta biosimilar reimbursement policy by sharing international experiences in this area, and the perspectives of key stakeholders.

Physicians as Stewards of Resources Summary Report

May 20, 2016

| IHE Institute of Health Economics

The Institute of Health Economics (IHE) together with the O’Brien Institute for Public Health (O’Brien Institute) held a policy forum on February 8th, 2016, entitled Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration to inform decision-making regarding the fiscal sustainability of theprovincial healthcare system, with a specific…

Health Technology Assessment on the Net: 2016

May 05, 2016

| IHE Institute of Health Economics

This guide has been developed by the information specialists at the Institute of Health Economics in Edmonton Alberta and is intended to facilitate searching for health technology assessments (HTAs) or systematic reviews by providing the list of current and reliable internet-based resources that we regularly use in our work. We have tried as much as possible to match this guide…

Newborn blood spot screening for galactosemia, tyrosiemia type I, homocystinuria,sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease and severe combined immunodeficiency

March 23, 2016

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle…

Post policy implementation review (PPIR) of rapid fetal fibronectin testing for preterm labour in Alberta

July 07, 2015

| IHE Institute of Health Economics

Written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an assessment of how the adoption of fFN testing in Alberta impacted the clinical management of preterm labour and healty system resources. This was also an opportunity to retroactively use the Post Policy Implementation Framework to evaluate a specific policy developed within…

Hysteroscopic tubal sterilization

September 30, 2014

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the clinical effectiveness and safety of hysteroscopic tubal sterilization, and the value for money associated with adopting hysteroscopic tubal sterilization in Alberta. Section Authors: Section One – Background and Context: Carmen…

Endovenous Ablation Interventions for Symptomatic Varicose Veins of the Legs

September 30, 2014

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the best available research evidence on the safety and effectiveness, cost effectiveness and budget impact of using Endovenous Laser Ablation (EVLA) or Endovenous Radiofrequency Ablation (RFA) in the management of symptomatic varicose…

First and second trimester prenatal screening update

August 31, 2014

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the safety, screening accuracy, therapeutic efficacy, patient outcomes and cost effectiveness of first trimester Quad (1T-Quad) +/- NT and NIPT screening for fetal trisomies. Section Authors: Section One – Technology Effectiveness and Safety: Ken Bond,…

Low dose computed tomography for the screening of lung cancer in adults

May 30, 2014

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the potential role of low dose computed tomography (LDCT) in screening for lung cancer in adults aged 50 years or older in Alberta. Section Authors: Section One – Social and System Demographics Analysis: Bing Guo, Dagmara Chojecki Section Two –…

Total prosthetic replacement of the temporomandibular joint: a rapid evidence assessment and economic analysis

May 03, 2013

| IHE Institute of Health Economics

This health technology assessment report has been produced in response to a request from Alberta Health (AH) as part of the Alberta Health Technologies Decision Process (AHTDP) to perform an evaluation of the scientific evidence on the safety and effectiveness of TMJ Concepts® and Biomet® Microfixation TMJ prostheses for adults who are indicated for total TMJ replacement.…

Transcutaneous Bilirubinometry for the Screening of Neonatal Hyperbilirubinemia

April 03, 2013

| IHE Institute of Health Economics

Transcutaneous Bilirubinometry for the Screening of Hyperbilirubinemia in Neonates ≥35 Weeks’ Gestation This report was prepared for Alberta Health Services (AHS) and focuses on the published evidence about the safety, test accuracy, and clinical impact of the use of transcutaneous bilirubin (TcB) test for the screening of significant hyperbilirubinemia in term or late…

Islet transplantation for the treatment of type 1 diabetes

February 13, 2013

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of the 2008 report on islet transplantation (IT) for Type 1 diabetes (T1DM). Section One of this analysis was intended to describe the profile of T1DM (definition, progression, epidemiology, and population dynamics of affected adults in Alberta, in Canada,…

The Effectiveness and Safety of Preschool Hearing Screening Programs

November 23, 2012

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report performs an evaluation of the scientific evidence on the safety, performance, and effectiveness of universal and targeted preschool hearing screening (PHS) to inform the Infant and Preschool Screening Framework being developed by the Community and Public Health (CPH)…

The Safety and Effectiveness of Preschool Vision Screening

November 05, 2012

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This review focused on the best evidence available on the use of PSVS to detect vision conditions in asymptomatic preschool children (aged from birth to 6 years; not necessarily considered at risk for developing visual impairment) to determine the safety and efficacy/effectiveness…

The Safety and Efficacy/Effectiveness of Using Automated Testing Devices for Universal Newborn Hearing Screening: An Update

October 14, 2012

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of a 2007 report. Permanent congenital hearing impairment/loss (PCHI/PCHL) is one of the most common congenital anomalies found at birth which can lead to delays and deficits in the development of speech, language, cognition, and learning, as well as…

First and Second Trimester Prenatal Screening for Trisomies 13, 18, and 21, and Open Neural Tube Defects

September 01, 2012

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an epidemiological profile of fetal aneuploidy and open neural tube defects (ONTD); describes the patterns of care, utilization trends, and factors affecting the provision of first and second trimester screening (FASTs) services for fetal aneuploidy and…

Bariatric treatments for adult obesity

March 20, 2012

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report summarizes available key information on the use of bariatric treatments for adult obesity in Alberta and North America (mainly Canada). This analysis was intended to describe the profile of adult obesity (definition, progression, epidemiology, and population dynamics…

Insulin pump therapy for type 1 diabetes

March 20, 2012

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the research evidence on the safety and efficacy of insulin pump therapy, as compared to multiple daily insulin injections, in the treatment of children, adults, and pregnant women diagnosed with type 1 diabetes. The report also analyses the economic impact…

Frameworks for post-policy implementation review

March 01, 2012

| IHE Institute of Health Economics

This report describes a framework for evaluating policies developed within the Alberta Health Technologies Decision Process (AHTDP) to strengthen the link between policy development and evidence. The framework was designed as a foundation upon which to build a more detailed and contextualized evaluative process in consultation with all stakeholders who are likely to be affected…

Human papillomavirus (HPV) Testing in Alberta

May 01, 2009

| IHE Institute of Health Economics

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is about testing for Human Papillomavirus (HPV). HPV is one of the most common sexually transmitted infections and can also cause cervical cancer. Cervical screening aims to reduce cervical cancer incidence and mortality by detecting precancerous lesions early. Until…

Screening Newborns for Hearing

February 13, 2007

| IHE Institute of Health Economics

The use of the automated auditory brainstem response and otoacoustic emissions tests for newborn hearing screening. Permanent congenital hearing impairment/loss (PCHI) is one of the most common congenital anomalies found at birth which can be expected to lead to delays and deficits in the development of speech, language, cognition and learning, as well as secondary effects on the…

  • Site Map
  • Privacy Policy
  • Contact Us & Subscribe
  • Home

Copyright © 2021 Institute of Health Economics

Institute of Health Economics 1200 10405 Jasper Avenue Edmonton, AB, Canada T5J 3N4

P: (1) 780.448.4881 F: (1) 780.448.0018
Email: [email protected]

Links

Canada

United States

United Kingdom

Other International

Journals

Health Economics Resources

Free Database Access

Never miss an update!

Subscribe to IHE